This was a retrospective audit assessing vancomycin dosing of 60 mg/kg/day in the attainment of therapeutic concentrations between 10–20 mcg/mL among 56 pediatric oncology patients. Twelve patients (21%) achieved therapeutic concentrations of 10–20 mcg/mL, while 44 patients (79%) obtained trough levels below 10 mcg/mL despite the addition of nephrotoxic agents
Vancomycin is not nephrotoxic by itself but many patients using it with other nephrotoxic agents sho...
This study aimed to suggest an initial pediatric vancomycin dose regimen through population pharmaco...
Artículo de publicación SciELOBackground: In critically ill pediatric patients vancomycin distributi...
This was a retrospective audit assessing vancomycin dosing of 60 mg/kg/day in the attainment of ther...
BACKGROUND: Gram-positive bacteremia is a common infection in pediatric oncology and stem cell trans...
To obtain pharmacokinetic and pharmacodynamic data for vancomycin in a cohort of critically ill pedi...
OBJECTIVE: To describe the relationships between dosing strategy, age, and vancomycin trough concent...
Background: Vancomycin is used primarily for Gram-positive infections. Recommended dosage regimens a...
International audienceIn pediatric cancer patients, determination of optimal vancomycin dosage is es...
AIMS: Vancomycin is frequently used in critically ill children in whom the drug pharmacokinetics are...
Background: Vancomycin is widely prescribed to treat infections caused by methicillin-resistant Stap...
Background: Vancomycin is widely used to treat infections caused by methicillin-resistant Staphyloco...
BACKGROUND: Usual treatment regimens with vancomycin often fail to provide adequate serum levels in ...
Study Objectives To determine whether a relationship exists between initial serum vancomycin trough ...
Monitoring of vancomycin trough concentrations is recommended for pediatric patients in the product ...
Vancomycin is not nephrotoxic by itself but many patients using it with other nephrotoxic agents sho...
This study aimed to suggest an initial pediatric vancomycin dose regimen through population pharmaco...
Artículo de publicación SciELOBackground: In critically ill pediatric patients vancomycin distributi...
This was a retrospective audit assessing vancomycin dosing of 60 mg/kg/day in the attainment of ther...
BACKGROUND: Gram-positive bacteremia is a common infection in pediatric oncology and stem cell trans...
To obtain pharmacokinetic and pharmacodynamic data for vancomycin in a cohort of critically ill pedi...
OBJECTIVE: To describe the relationships between dosing strategy, age, and vancomycin trough concent...
Background: Vancomycin is used primarily for Gram-positive infections. Recommended dosage regimens a...
International audienceIn pediatric cancer patients, determination of optimal vancomycin dosage is es...
AIMS: Vancomycin is frequently used in critically ill children in whom the drug pharmacokinetics are...
Background: Vancomycin is widely prescribed to treat infections caused by methicillin-resistant Stap...
Background: Vancomycin is widely used to treat infections caused by methicillin-resistant Staphyloco...
BACKGROUND: Usual treatment regimens with vancomycin often fail to provide adequate serum levels in ...
Study Objectives To determine whether a relationship exists between initial serum vancomycin trough ...
Monitoring of vancomycin trough concentrations is recommended for pediatric patients in the product ...
Vancomycin is not nephrotoxic by itself but many patients using it with other nephrotoxic agents sho...
This study aimed to suggest an initial pediatric vancomycin dose regimen through population pharmaco...
Artículo de publicación SciELOBackground: In critically ill pediatric patients vancomycin distributi...